The settlement, announced on Wednesday, resolves 93% of all Zantac cases in state courts against GlaxoSmithKline.
GlaxoSmithKline has filed lawsuits against Moderna in the U.S., claiming infringement on its mRNA technology patents with ...
Hindustan Unilever Limited (HUL) has filed an appeal with the Commissioner of Income Tax, challenging a tax demand of Rs 962 crore related to its acquisition of the ‘Horlicks’ brand from ...
Pharmaceutical firm GlaxoSmithKline (GSK) announced Tuesday it received approval from the Food and Drug Administration (FDA) ...
In a report released on October 10, David Evans from Kepler Capital maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), ...
GlaxoSmithKline Pharma, celebrating 100 years in India, is shifting to a specialty-focused model by entering the oncology ...
GlaxoSmithKline Pharmaceuticals Ltd. engages in the business of manufacturing, distributing and trading in pharmaceuticals. The company's product portfolio includes prescription medicines and ...
周四,全球投资银行杰富瑞证券调整了GlaxoSmithKline (GSK:LN) (NYSE: GSK)的股票目标价,将其从之前的21.00英镑下调至20.00英镑。尽管如此,该公司仍维持对这家制药公司股票的"买入"评级。 此次修正是因为分析师预计GlaxoSmithKline第三季度的销售和利润可能低于市场预期,主要原因是美国Arexvy的表现不如预期。然而,分析师指出,该公司预计将重申其20 ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Citi analyst Peter Verdult maintained a Buy rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £19.00. The ...